Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 12/20 | 0.47 |
| ▸ | CTSS | P25774 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.39 |
| ▸ | HTR3B | O95264 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | HTR3A | P46098 | 1/20 | 0.39 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.39 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.38 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.38 |
| ▸ | CCR5 | P51681 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7238735 | 0.93 | CAPN1 (0.53) | CAPN1CTSSTSHRHSD17B10HTR3E | |
| SCHEMBL7235830 | 0.89 | CAPN1 (0.56) | CAPN1CTSSTSHRHSD17B10HTR3E | |
| SCHEMBL7243236 | 0.89 | L3MBTL1 (0.49) | CAPN1CTSSTSHRHSD17B10 | |
| SCHEMBL7242879 | 0.88 | CAPN1 (0.47) | CAPN1CTSSTSHRHSD17B10HTR3E | |
| SCHEMBL7238926 | 0.85 | CAPN1 (0.49) | CAPN1CTSSHSD17B10 | |
| SCHEMBL7243415 | 0.83 | CAPN1 (0.47) | CAPN1CTSSTSHRHSD17B10CHIA | |
| SCHEMBL7235428 | 0.83 | CAPN1 (0.57) | CAPN1CTSSTSHRHSD17B10 | |
| SCHEMBL7234263 | 0.82 | KMT2A (0.49) | TSHRHSD17B10HTR3EHTR3BHTR1A | |
| SCHEMBL7232128 | 0.81 | CAPN1 (0.49) | CAPN1CTSSTSHRHSD17B10HTR3E | |
| SCHEMBL7242851 | 0.81 | CHIA (0.58) | CAPN1CTSSTSHRHSD17B10CHIA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6562827-B1 | For the treatment of diseases in which increased calpain activity occurs such as neurodegenerative diseases or neuronal damage are caused by ischemia, trauma or mass hemorrhages | ABBOTT LABORATORIES | 2003-05-13 | — | — | US | disclosed |